20 related articles for article (PubMed ID: 1738116)
1. Assessing the effect of breed, age, and sex on muscarinic receptor distribution in atria and ventricles of turkeys.
Schoeller C; Abraham G
Poult Sci; 2024 Feb; 103(2):103275. PubMed ID: 38042041
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Blood Flow in the Cerebral Posterior Circulation by Parasympathetic Nerve Fibers: Physiological Background and Possible Clinical Implications in Patients With Vertebrobasilar Stroke.
Tamayo A; Siepmann T
Front Neurol; 2021; 12():660373. PubMed ID: 34777191
[TBL] [Abstract][Full Text] [Related]
3. Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?
Roloff EV; Tomiak-Baquero AM; Kasparov S; Paton JF
J Physiol; 2016 Nov; 594(22):6463-6485. PubMed ID: 27357059
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of oxomemazine for the M1 muscarinic receptors.
Lee SW; Woo CW; Kim JG
Arch Pharm Res; 1994 Dec; 17(6):443-51. PubMed ID: 10319156
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature.
Chowienczyk PJ; Cockcroft JR; Ritter JM
Br J Pharmacol; 1993 Oct; 110(2):736-8. PubMed ID: 8242245
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.
Linville DG; Hamel E
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):179-86. PubMed ID: 7477441
[TBL] [Abstract][Full Text] [Related]
7. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
8. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
9. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
Endou M; Hattori Y; Gando S; Kanno M
J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
[TBL] [Abstract][Full Text] [Related]
11. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
12. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
Dauphin F; Hamel E
J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
